What is the recommended pediatric dose of Ceftriaxone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing of Ceftriaxone

The recommended pediatric dose of ceftriaxone is 50-100 mg/kg/day given once daily or divided every 12-24 hours, with a maximum daily dose of 4 grams for most infections. 1

Dosing by Indication

Standard Infections

  • General infections: 50-75 mg/kg/day given once daily or divided every 12 hours
    • Maximum daily dose: 2 grams 1
  • Skin and skin structure infections: 50-75 mg/kg/day once daily or divided twice daily
    • Maximum daily dose: 2 grams 1
  • Acute otitis media: Single intramuscular dose of 50 mg/kg
    • Maximum dose: 1 gram 1

Severe Infections

  • Meningitis: 100 mg/kg as initial dose (not exceeding 4 grams), followed by 100 mg/kg/day
    • Can be given once daily or divided every 12 hours
    • Maximum daily dose: 4 grams
    • Duration: 7-14 days 1
  • Bacterial pneumonia: 50-100 mg/kg/day
    • For penicillin-resistant S. pneumoniae: 100 mg/kg/day 2, 3

Administration Methods

Intravenous Administration

  • Should be administered over 30 minutes
  • Exception: In neonates, administer over 60 minutes to reduce risk of bilirubin encephalopathy 1
  • Reconstitute with appropriate IV diluent to concentration between 10-40 mg/mL 1

Intramuscular Administration

  • Inject well within the body of a relatively large muscle
  • Aspirate to avoid unintentional injection into blood vessel 1

Special Considerations

Age-Specific Dosing

  • Neonates:
    • Postnatal age ≤7 days: 50 mg/kg/day given every 24 hours
    • Postnatal age >7 days and ≤2000g: 50 mg/kg/day given every 24 hours
    • Postnatal age >7 days and >2000g: 50-75 mg/kg/day given every 24 hours 2
    • Important: Should not be used in hyperbilirubinemic neonates 2

Renal/Hepatic Impairment

  • No dosage adjustment necessary for patients with impairment of renal or hepatic function 1

Once vs. Twice Daily Dosing

The most recent evidence supports different approaches based on the infection type:

  • For most infections, once-daily dosing (50-100 mg/kg/day) is effective and convenient 4, 5
  • For meningitis, once-daily dosing (100 mg/kg/day) achieves higher 24-hour probability of target attainment (88% vs 53%) compared to twice-daily dosing 6
  • For critically ill children with high creatinine clearance or when targeting less susceptible pathogens (MIC ≥0.5 mg/L), twice-daily dosing (50 mg/kg every 12 hours) may provide better target attainment 7, 8

Duration of Therapy

  • Generally, ceftriaxone therapy should be continued for at least 2 days after signs and symptoms of infection have disappeared 1
  • Usual duration: 4-14 days; longer therapy may be required for complicated infections 1
  • For Streptococcus pyogenes infections: minimum 10 days 1

Common Pitfalls to Avoid

  • Compatibility issues: Do not use diluents containing calcium (e.g., Ringer's solution) to reconstitute ceftriaxone as particulate formation can result 1
  • Inappropriate dosing frequency: Consider twice-daily dosing for critically ill patients with enhanced renal clearance or when targeting less susceptible pathogens 8
  • Inadequate duration: Ensure treatment continues for at least 48-72 hours after clinical improvement 3
  • Inappropriate use in neonates with hyperbilirubinemia: Ceftriaxone should not be used in hyperbilirubinemic neonates 2

By following these evidence-based dosing recommendations, clinicians can optimize the efficacy and safety of ceftriaxone therapy in pediatric patients while minimizing the risk of treatment failure and antimicrobial resistance.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.